Analysts think CAPR stock price could increase by 198%
Jun 08, 2025, 11:26 AM
-34.86%
What does CAPR do
Capricor Therapeutics, based in Beverly Hills, develops biological therapies for serious medical conditions, focusing on CAP-1002 for Duchenne muscular dystrophy in Phase 3 trials. The company also utilizes exosome technology for various therapeutic applications.
10 analysts think CAPR stock price will increase by 197.78%. The current median analyst target is $42.33 compared to a current stock price of $14.21. The lowest analysts target is $25.25 and the highest analyst target is $80.85.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.